Request Deal Involvement
US WorldMeds completed the acquisition of four cell therapy assets from Adaptimmune for $55m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Ropes & Gray
financial advisors
TD Cowen
legal advisors
Gibson Dunn & Crutcher
debt providers
Oaktree Capital Management
debt providers
Athyrium Capital Management
legal advisors to debt providers
Sullivan & Cromwell
or
Principals
target
ADAPTIMMUNE [FOUR CELL THERAPY ASSETS]
vendor
ADAPTIMMUNE THERAPEUTICS PLC
bidder
US WORLDMEDS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite